<H1> Global Nutraceutical CDMO Market: Growing Focus on Personalized Nutrition and 8% CAGR by 2030 </H1>
<img class="alignnone size-full wp-image-1805" src="http://dailyinvestorhub.com/wp-content/uploads/2025/05/Nutra_CDMO1.png" alt="" width="747" height="473" />

<strong><em>The </em></strong><a href="https://meditechinsights.com/nutraceutical-cdmo-market/"><strong><em>nutraceutical CDMO</em></strong>Â <strong><em>market</em></strong></a><strong><em> is anticipated to expand at a CAGR of ~8% during the forecast period.Â </em></strong>Key drivers of this growth include rising demand for nutraceutical products, technological advancements in manufacturing, shift towards plant-based and ayurvedic supplements, expanding nutraceutical applications, growing outsourcing trends in the nutraceutical industry, adoption of sedentary lifestyle &amp; rising aging population, and increasing consumer focus on wellness and personalized nutrition.

A nutraceutical CDMO (Contract Development and Manufacturing Organization) is a company that provides outsourced services for the development, formulation, manufacturing, and packaging of nutraceutical products on behalf of brand owners and health supplement companies.

<strong>To request a free sample copy of this report, please visit below
</strong><a href="https://meditechinsights.com/nutraceutical-cdmo-market/request-sample/">https://meditechinsights.com/nutraceutical-cdmo-market/request-sample/</a>

<strong>Rising demand for nutraceutical products driving the growth of the nutraceutical CDMO market</strong>

Nutraceutical products encompass a wide range of substances and food items that offer medical or health benefits beyond basic nutrition, aiming to support disease prevention and treatment. As dietary habits evolve, the demand for these products continues to rise, driven by increasing consumer awareness, the growing prevalence of non-communicable diseases, and escalating healthcare costs. Additionally, the consumption of multivitamins is expected to surge as consumers prioritize immune system support, a trend that gained significant momentum during the COVID-19 pandemic and is likely to persist in the future. To meet these shifting consumer demands, nutraceutical companies are increasingly partnering with CDMOs for cost-effective, large-scale production, advanced R&amp;D capabilities, and regulatory compliance. With stringent FDA and global regulations, CDMOs provide essential expertise in quality assurance, labeling, and clinical trials, ensuring that brands deliver high-quality, compliant products to market. The rapid expansion of e-commerce and direct-to-consumer (DTC) brands has further accelerated the need for private-label manufacturing and turnkey solutions. As the nutraceutical industry continues its rapid growth, CDMOs play a vital role in helping brands scale efficiently, develop innovative formulations, and cater to the increasing consumer demand for health and wellness solutions.

<strong>Growing outsourcing trends in the nutraceutical industry fuel its demand</strong>

Nutraceuticals and dietary ingredients such as probiotics, folic acid, and fish oil offer significant health benefits, including supporting biological processes that help prevent chronic diseases, promoting healthy aging, and maintaining the body's structure and function. As nutraceutical companies capitalize on this growing market, many are turning to specialized CDMOs with expertise in fine chemicals. CDMOs provide end-to-end solutions, including R&amp;D, formulation, raw material sourcing, production, packaging, and labeling, allowing companies to focus on branding, marketing, and distribution while outsourcing manufacturing complexities. This approach helps streamline production, reduce costs, and enhance product quality while ensuring compliance with industry regulations. Key ways CDMOs support the growth of nutraceutical companies include reduced capital investment, regulatory compliance expertise, advanced manufacturing capabilities, and efficient development cycles.

<strong>Competitive Landscape Analysis</strong>

The global nutraceutical CDMO market is marked by the presence of established and emerging market players such asÂ <strong>Catalent Inc.; Lonza; NutraScience Labs; Robinson Pharma, Inc.; Health Wright Products, Inc.; INPHARMA S.p.A.;Â Aenova Group; NutraPakUSA;Â SFI Health; Eurofins; WuXi AppTec; and Charles River Laboratories;Â </strong>among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

<strong>ðŸ”— Want deeper insights? Download the sample report here:
</strong><a href="https://meditechinsights.com/nutraceutical-cdmo-market/request-sample/">https://meditechinsights.com/nutraceutical-cdmo-market/request-sample/</a>

<strong>Market Segmentation</strong>

This report by Medi-Tech Insights provides theÂ size of the global nutraceutical CDMO market at theÂ regional- and country-level from 2023 to 2030. The report further segments the market based on dosage form, service type, and company size.
<ul>
 	<li><strong>Market Size &amp; Forecast (2023-2030), By Dosage Form, USD Million</strong>
<ul>
 	<li>Tablets &amp; Capsules</li>
 	<li>Softgel</li>
 	<li>Powder</li>
 	<li>Others</li>
</ul>
</li>
 	<li><strong>Market Size &amp; Forecast (2023-2030), By Service Type, USD Million</strong>
<ul>
 	<li>Product Formulation and Development</li>
 	<li>Research &amp; Development (R&amp;D)</li>
 	<li>Manufacturing and Packaging</li>
 	<li>Regulatory Compliance</li>
 	<li>Others</li>
</ul>
</li>
 	<li><strong>Market Size &amp; Forecast (2023-2030), By Company Size, USD Million</strong>
<ul>
 	<li>Small Companies</li>
 	<li>Mid-Sized Companies</li>
 	<li>Large Companies</li>
</ul>
</li>
 	<li><strong>Market Size &amp; Forecast (2023-2030), By Region, USD Million</strong>
<ul>
 	<li>North America
<ul>
 	<li>US</li>
 	<li>Canada</li>
</ul>
</li>
 	<li>Europe
<ul>
 	<li>UK</li>
 	<li>Germany</li>
 	<li>France</li>
 	<li>Italy</li>
 	<li>Spain</li>
 	<li>Rest of Europe</li>
</ul>
</li>
 	<li>Asia Pacific
<ul>
 	<li>China</li>
 	<li>India</li>
 	<li>Japan</li>
 	<li>Rest of Asia Pacific</li>
</ul>
</li>
 	<li>Latin America</li>
 	<li>Middle East &amp; Africa</li>
</ul>
</li>
</ul>
<strong>About Medi-Tech Insights</strong>

Medi-Tech Insights is a healthcare-focused business research &amp; insights firm. Our clients include Fortune 500 companies, blue-chip investors &amp; hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices &amp; Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis &amp; go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

<strong>Contact:</strong>

Ruta Halde
Associate, Medi-Tech Insights
<u>Â +32 498 86 80 79
</u><a href="mailto:info@meditechinsights.com">info@meditechinsights.com</a><u>Â </u>
